Free Trial
$100 Off. Every Year. Lock In MarketBeat All Access at $149
Claim the Rate Lock
Claim MarketBeat All Access Sale Promotion
NYSE:ABT

Abbott Laboratories Q3 2026 Earnings Date & Estimates

Abbott Laboratories logo
$104.79 -0.10 (-0.10%)
Closing price 10/16/2026 03:59 PM Eastern
Extended Trading
$104.16 -0.63 (-0.60%)
As of 07:00 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Abbott Laboratories is estimated to report Q3 2026 earnings on Wednesday, October 21, 2026, before market opens. The conference call is scheduled for 9:00 AM ET.

Research:ProfileEarnings HistoryForecast

Upcoming Earnings Announcement

Quarter
Q3 2026
Announcement Date
Time
Before Market Opens
Conference Call
9:00 AM ET
Google Calendar (opens in a new tab)Outlook (opens in a new tab)Yahoo Calendar (opens in a new tab)

What Analysts Expect from Abbott Laboratories in Q3 2026

Abbott Laboratories is expected to post earnings of $1.42 per share on revenue of $12.99 billion. In the same quarter a year earlier Abbott Laboratories reported $1.30 per share on revenue of $11.37 billion. Abbott Laboratories last reported on July 16, 2026, posting $1.31 per share and beating the $1.28 consensus estimate. Abbott Laboratories has beaten the consensus EPS estimate in 4 of its last 8 quarters.

Consensus Estimates

Consensus EPS
$1.42
Expected Revenue
$12.99 billion
Prior-Year EPS
$1.30
Prior-Year Revenue
$11.37 billion
Expected EPS Growth
+9.2%
Expected Revenue Growth
+14.3%

Recent Track Record

Last Reported
Q2 2026
Last Quarter EPS
$1.31 (Beat by +$0.03)
Last Quarter Revenue
$12.59 billion
EPS Beat Rate
4 of last 8 quarters

Prepare for the Q3 2026 Call

Abbott Laboratories Q3 2026 Earnings FAQ

Abbott Laboratories (NYSE:ABT) is estimated to report Q3 2026 earnings on Wednesday, October 21, 2026, before market opens. This date is estimated from past reporting schedules and may change once the company confirms it.

Abbott Laboratories' Q3 2026 earnings conference call is scheduled for Wednesday, October 21, 2026 at 9:00 AM ET. MarketBeat streams the conference call audio and posts the transcript as soon as possible on the earnings announcement date.

Analysts expect Abbott Laboratories to post earnings of $1.42 per share for Q3 2026.

The consensus revenue estimate for Abbott Laboratories is $12.99 billion for Q3 2026.

Abbott Laboratories Earnings Headlines

Tamboran Resources appoints Todd Abbott managing director as Beetaloo moves into development
October 18 at 9:24 PM  |  proactiveinvestors.comhttps://www.proactiveinvestors.com/companies/news/1100264/tamboran-resources-appoints-todd-abbott-managing-director-as-beetaloo-moves-into-development-1100264.html
Abbott Laboratories (NYSE:ABT) Stock Rating Reaffirmed as "Buy" by TD Cowen
October 18 at 1:36 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31129616
Small Colorado Company (Backed by Sam Altman) Could Save U.S. Power Grid
A small Colorado company has secured rights to technology that could prevent the U.S. public power grid from collapsing — and billionaire Sam Altman is now an investor. This under-the-radar firm is drawing serious attention from those watching the energy infrastructure space closely.tc pixel
October 19 at 1:00 AM  |  Altimetry (Ad)
Analysts Are Bullish on Top Healthcare Stocks: Abbott Laboratories (ABT), PROCEPT BioRobotics (PRCT)
October 17 at 11:10 AM  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/stocks/ABT/pressreleases/8137230/analysts-are-bullish-on-top-healthcare-stocks-abbott-laboratories-abt-procept-biorobotics-prct/
Abbott Laboratories (ABT) Launches Ensure Max Protein As Undervalued View Faces A Fresh Test
October 16 at 2:51 PM  |  finance.yahoo.comhttps://finance.yahoo.com/markets/stocks/articles/abbott-laboratories-abt-launches-ensure-140937143.html
Countdown to Abbott (ABT) Q3 Earnings: A Look at Estimates Beyond Revenue and EPS
October 16 at 9:41 AM  |  finance.yahoo.comhttps://finance.yahoo.com/markets/stocks/articles/countdown-abbott-abt-q3-earnings-121527686.html
See More Abbott Laboratories Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Abbott Laboratories? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Abbott Laboratories and other key companies, straight to your email.

About Abbott Laboratories

Abbott Laboratories (NYSE:ABT) is a global healthcare company that develops, manufactures and markets a broad range of medical products and services. Founded in 1888 by Wallace C. Abbott, the company is headquartered in Abbott Park, Illinois, and serves patients, healthcare providers and consumers in markets around the world.

Abbott operates across four principal businesses: medical devices, diagnostics, nutrition and established pharmaceutical products. Its offerings include glucose-monitoring systems such as FreeStyle Libre; cardiovascular devices, including stents and structural heart products; laboratory and point-of-care diagnostic systems; and branded generic medicines in areas such as gastroenterology, women’s health and cardiometabolic care.

The company’s nutrition portfolio includes infant and pediatric products such as Similac and PediaSure, adult nutritional products such as Ensure, and rehydration products such as Pedialyte. Robert B. Ford serves as Abbott’s chairman and chief executive officer.

View Abbott Laboratories Profile
Earnings Tools